Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2006; 48:924-930, doi:10.1016/j.jacc.2006.06.047 (Published online 15 August 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (61)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jo, S.-H.
Right arrow Articles by Kim, H.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jo, S.-H.
Right arrow Articles by Kim, H.-S.

Renal Toxicity Evaluation and Comparison Between Visipaque (Iodixanol) and Hexabrix (Ioxaglate) in Patients With Renal Insufficiency Undergoing Coronary Angiography

The RECOVER Study: A Randomized Controlled Trial

Sang-Ho Jo, MD*,1, Tae-Jin Youn, MD*,1, Bon-Kwon Koo, MD*,*, Jin-Shik Park, MD*, Hyun-Jae Kang, MD*, Young-Seok Cho, MD*, Woo-Young Chung, MD*, Gwon-Wook Joo, MD{dagger}, In-Ho Chae, MD*, Dong-Ju Choi, MD*, Byung-Hee Oh, MD*, Myoung-Mook Lee, MD{ddagger}, Young-Bae Park, MD* and Hyo-Soo Kim, MD*,*

* Division of Cardiology, Department of Internal Medicine, Seoul National University College of Medicine/Cardiovascular Center, Seoul National University Hospital, Seoul, Korea
{dagger} Division of Nephrology, Department of Internal Medicine, Seoul National University College of Medicine/Cardiovascular Center, Seoul National University Hospital, Seoul, Korea
{ddagger} Cardiovascular Center, Dongguk University International Hospital, Goyang-si, Gyeonggi-do, Korea.


Figure 1
View larger version (12K):

[in a new window]
 
Figure 1 Flow of patients through the study.

 

Figure 2
View larger version (28K):

[in a new window]
 
Figure 2 Incidence of contrast-induced nephropathy according to 3 definitions for patients receiving iodixanol and ioxaglate as contrast media for coronary angiography. SCr = serum creatinine.

 

Figure 3
View larger version (20K):

[in a new window]
 
Figure 3 Changes in SCr concentration (baseline to peak) after contrast administration for coronary angiography. Baseline and peak SCr concentrations within 48 h after contrast administration are shown for each patient in the iodixanol (n = 140) and ioxaglate (n = 135) study arms. The vertical lines and symbols illustrate the mean (± SD) baseline and peak SCr values for the 2 groups as described in the text; p values refer to the difference between baseline and peak SCr for iodixanol and ioxaglate, respectively. See text for additional details. To convert values for creatinine to micromoles per liter, multiply by 88.4. mOsm/kg = milliosmoles per 1,000 grams; mPa·s = millipascal seconds; SCr = serum creatinine; SD = standard deviation.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement